End-of-day quote
Other stock markets
|
||
- CAD | - |
15/05 | Transcript : MediPharm Labs Corp., Q1 2024 Earnings Call, May 15, 2024 | |
15/05 | MediPharm Labs Q1 Gross Profit, Rise | MT |
Business Summary
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Canadian Adult Use and Wellness
31.0
%
| 13 | 60.2 % | 10 | 31.0 % | -22.96% |
Canadian Medical Cannabis - Other
29.9
%
| - | - | 10 | 29.9 % | - |
International Medical Cannabis
29.2
%
| 5 | 22.9 % | 10 | 29.2 % | +90.34% |
Canadian Medical Cannabis - Clinics
5.6
%
| - | - | 2 | 5.6 % | - |
Pharmaceutical and Business to Business
4.2
%
| 4 | 16.8 % | 1 | 4.2 % | -62.52% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Canada
69.8
%
| 15 | 66.4 % | 23 | 69.8 % | +57.17% |
Australia
16.3
%
| 3 | 11.8 % | 5 | 16.3 % | +106.63% |
Germany
10.8
%
| 4 | 16.5 % | 4 | 10.8 % | -1.89% |
Other
3.0
%
| 1 | 5.3 % | 1 | 3.0 % | -14.02% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Pidduck
CEO | Chief Executive Officer | - | 20/22/20 |
Greg Hunter
DFI | Director of Finance/CFO | - | 08/21/08 |
Keith Strachan
PSD | President | - | 01/18/01 |
William Gordon
CTO | Chief Tech/Sci/R&D Officer | - | 01/16/01 |
Kirk Binns
AUD | Comptroller/Controller/Auditor | - | 06/19/06 |
Ahmed Shehata
LAW | General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Bumby
BRD | Director/Board Member | 60 | 01/23/01 |
David Pidduck
CEO | Chief Executive Officer | - | 20/22/20 |
Shelley Martin
BRD | Director/Board Member | - | 22/20/22 |
Chris Halyk
BRD | Director/Board Member | - | 04/20/04 |
Keith Strachan
PSD | President | - | 01/18/01 |
Chris Taves
CHM | Chairman | - | 13/20/13 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 404,023,889 | 385,712,877 ( 95.47 %) | 0 | 95.47 % |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+41.50% | 6.2B | |
-22.89% | 4.1B | |
+9.36% | 3.41B | |
-19.39% | 2.83B | |
-11.05% | 2.29B | |
+45.24% | 1.93B | |
-7.51% | 1.52B | |
+46.81% | 1.51B | |
-18.04% | 1.49B |
- Stock Market
- Equities
- LABS Stock
- Stock
- Company Medipharm Labs Corp